Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications.
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE ER TABLETS |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | Ascend Laboratories, LLC, Parsippany, NJ, 07054 |
| NDC | 67877-590-01 |
| Full product label | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01. |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | Nationwide in the USA |
| Quantity | 9216 bottles |
| Recall initiated | 2022-01-12 |
| Report date | 2022-02-02 |
| Recall completed | 2023-05-31 |
| Recall number | D-0393-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗